| Kohde | Arvo |
|---|---|
| DrugBank ID | DB00571 |
| Näyttötaso | L5 (Laskennallinen Ennuste) |
| Ennustettujen Indikaatioiden Määrä | 28 |
Seuraavat ovat TxGNN-mallin ennustamia mahdollisia uusia indikaatioita. Korkeammat pisteet osoittavat suurempaa ennustettua merkitystä.
| # | Indikaatio | Lähde |
|---|---|---|
| 1 | congenital hemangioma | TxGNN Knowledge Graph |
| 2 | cavernous hemangioma | TxGNN Knowledge Graph |
| 3 | hypertrophic cardiomyopathy | TxGNN Knowledge Graph |
| 4 | glomus tumor | TxGNN Knowledge Graph |
| 5 | laryngotracheal angioma | TxGNN Knowledge Graph |
| 6 | hypertensive disorder | TxGNN Knowledge Graph |
| 7 | retiform hemangioendothelioma | TxGNN Knowledge Graph |
| 8 | primary intraosseous venous malformation | TxGNN Knowledge Graph |
| 9 | familial hypertrophic cardiomyopathy | TxGNN Knowledge Graph |
| 10 | multifocal atrial tachycardia (disease) | TxGNN Knowledge Graph |
| 11 | cavernous hemangiomas of face-supraumbilical midline raphe syndrome | TxGNN Knowledge Graph |
| 12 | verrucous hemangioma | TxGNN Knowledge Graph |
| 13 | atrial fibrillation (disease) | TxGNN Knowledge Graph |
| 14 | placental hemangioma | TxGNN Knowledge Graph |
| 15 | hereditary neurocutaneous angioma | TxGNN Knowledge Graph |
| 16 | pulmonary venoocclusive disease | TxGNN Knowledge Graph |
| 17 | epithelioid hemangioendothelioma | TxGNN Knowledge Graph |
| 18 | lymphangioma | TxGNN Knowledge Graph |
| 19 | composite hemangioendothelioma | TxGNN Knowledge Graph |
| 20 | primary intralymphatic angioendothelioma | TxGNN Knowledge Graph |
| 21 | spindle cell hemangioma | TxGNN Knowledge Graph |
| 22 | kaposiform hemangioendothelioma | TxGNN Knowledge Graph |
| 23 | Kasabach-Merritt syndrome | TxGNN Knowledge Graph |
| 24 | tufted angioma (disease) | TxGNN Knowledge Graph |
| 25 | retinal capillary malformation | TxGNN Knowledge Graph |
| 26 | His bundle tachycardia | TxGNN Knowledge Graph |
| 27 | hemangioma | TxGNN Knowledge Graph |
| 28 | hypertension | TxGNN Knowledge Graph |
Nämä ennusteet ovat vain tutkimustarkoituksiin eivätkä muodosta lääketieteellistä neuvontaa. Kliininen validointi vaaditaan ennen mitään kliinistä sovellusta.